Cigna Q2 2026 Earnings Overview
The Cigna Group (NYSE:CI) posted second‑quarter 2026 adjusted earnings of $7.78 per share, beating the analyst consensus of $7.59 by $0.19. Revenue for the quarter increased 7% year‑over‑year to $71.7 billion, surpassing the $70.18 billion estimate.
The company raised its full‑year 2026 adjusted earnings outlook to at least $30.45 per share, an increase of $0.10 from its prior projection and marginally above the consensus estimate of $30.41 per share.
Adjusted income from operations climbed 6% YoY to $2.1 billion, driven primarily by stronger contributions from Cigna Healthcare. Shareholders’ net income reached $1.7 billion, or $6.29 per share, compared with $1.5 billion, or $5.71 per share, in the second quarter of 2025.
Segment performance showed Cigna Healthcare’s adjusted revenues rising 9% to $11.7 billion, with adjusted operating income increasing 17% to $1.3 billion, reflecting improved margins in the U.S. Employer business. Evernorth Health Services reported adjusted revenues of $61.5 billion, up 6%, while its adjusted operating income fell 2% to $1.7 billion, attributed to client‑focused initiatives and large contract renewals.
Customer metrics indicated total medical customers grew 2% from year‑end 2025 to 18.4 million, whereas total pharmacy customers declined 4% to 118.2 million.
Brian C. Evanko, President and Chief Executive Officer, stated that leveraging technology, data and AI to deliver personalized experiences, improve access and lower costs is creating greater value, and that the strong second‑quarter results demonstrate progress against these priorities.
Following the announcement, Cigna’s shares fell approximately 1% in pre‑market trading.